Allozyne Garners $2,452,450 New Financing Round

  • Feed Type
  • Date
    8/19/2013
  • Company Name
    Allozyne
  • Mailing Address
    1600 Fairview Ave E Seattle, WA 98102
  • Company Description
    Allozyne, Inc., is a privately held biotechnology company focused on the development and manufacture of protein therapeutics. These technologies will enable the company to improve the efficacy of protein-based therapeutics.
  • Website
    http://www.allozyne.com
  • Transaction Type
    Debt
  • Transaction Amount
    $2,452,450
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Includes price of warrants. SEC regulatory filing. Not a solicitation.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.